Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,046 | 56,516 | 61,662 | 80,630 | 111,471 |
| TOTAL | $51,232 | $60,567 | $66,493 | $86,425 | $116,406 |
| Non-Current Assets | |||||
| PPE Net | 678 | 906 | 1,134 | 1,363 | 1,603 |
| Other Non-Current Assets | 512 | 763 | 1,011 | 1,409 | 1,649 |
| TOTAL | $1,190 | $1,669 | $2,145 | $2,772 | $3,252 |
| Total Assets | $52,422 | $62,236 | $68,638 | $89,197 | $119,658 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,704 | 18,211 | 15,800 | 17,751 | 26,720 |
| TOTAL | $14,540 | $19,462 | $17,462 | $19,260 | $28,344 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23,617 | 19,806 | 19,806 | 20,221 | 20,642 |
| TOTAL | $23,617 | $19,806 | $19,806 | $20,221 | $20,642 |
| Total Liabilities | $38,157 | $39,268 | $37,268 | $39,481 | $48,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,168 | 967 | 967 | 962 | 962 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -486,039 | -471,155 | -460,569 | -439,497 | -416,263 |
| TOTAL | $14,265 | $22,968 | $31,370 | $49,716 | $70,672 |
| Total Liabilities And Equity | $52,422 | $62,236 | $68,638 | $89,197 | $119,658 |